title: Therapeutic management of bone demineralization in the HIV-infected population.
authors.forename: Eugènia
authors.initials: E
authors.lastname: Negredo
authors.forename: Eva
authors.initials: E
authors.lastname: Martínez
authors.forename: Denise
authors.initials: D
authors.lastname: Cinquegrana
authors.forename: Carla
authors.initials: C
authors.lastname: Estany
authors.forename: Bonaventura
authors.initials: B
authors.lastname: Clotet
mesh_terms: D019386:Alendronate / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use; D015519:Bone Density / Q000502:physiology*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002136:Calcium, Dietary / Q000008:administration & dosage; D004164:Diphosphonates / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008019:Life Style
chemical_list: D019380:Anti-HIV Agents; D050071:Bone Density Conservation Agents; D002136:Calcium, Dietary; D004164:Diphosphonates; D019386:Alendronate